Product Information
GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION is a generic product labeled by Saptalis Pharmaceuticals LLC, priced at $0.2019 per ML under NDC 71656006116. Its NADAC has been published 86 times since Feb 12, 2025.
FDA first approved this application on Oct 7, 2024. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 mg/5mL
Manufacturer
Saptalis Pharmaceuticals LLCNDC
71656006116
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GLYCOPYRROLATEApproval Type
Generic (ANDA)
FDA Application
ANDA216297FDA Approved
10/7/2024
TE Code
AA
On Market Since
11/25/2024
Pharmacological Classes
Price Statistics
The NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has been published 86 times since Feb 12, 2025, and over the history we have for it it has declined 51.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2019 per ML |
|---|---|
| All-time high | $0.4173 (Feb 12, 2025) |
| All-time low | $0.1689 (May 20, 2026) |
| 52-week high | $0.2559 |
| 52-week low | $0.1689 |
| Median price | $0.2425 |
| Average price | $0.2439 |
| Largest weekly change | -15.1% (Feb 18, 2026) |
| Weeks tracked | 86 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the glycopyrrolate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Saptalis Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
glycopyrrolate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION, manufactured by Saptalis Pharmaceuticals LLC, is $0.2019 per ML (NDC 71656006116), effective Sep 30, 2026.
How has the price of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION changed over time?
Over the history we have for it, the NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has declined 51.6%. It has been tracked across 86 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
Since Feb 12, 2025, the NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has ranged from a low of $0.1689 (May 20, 2026) to a high of $0.4173 (Feb 12, 2025), with a median of $0.2425 per ML.
Are there cheaper alternatives to GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION (NDC 71656006116) is labeled by Saptalis Pharmaceuticals LLC, and CMS classifies it as a generic product.